$100 Invested In Freeport-McMoRan 20 Years Ago Would Be Worth This Much Today

Freeport-McMoRan (NYSE:FCX) has outperformed the market over the past 20 years by 1.16% on an annualized basis producing an average annual return of 8.55%. Currently, Freeport-McMoRan has a market capitalization of $49.22 billion.

Freeport-McMoRan (NYSE:FCX) has outperformed the market over the past 20 years by 1.16% on an annualized basis producing an average annual return of 8.55%. Currently, Freeport-McMoRan has a market capitalization of $49.22 billion.

Buying $100 In FCX: If an investor had bought $100 of FCX stock 20 years ago, it would be worth $538.13 today based on a price of $34.44 for FCX at the time of writing.

Freeport-McMoRan’s Performance Over Last 20 Years

comp_fig

Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Recap: Immunome Q2 Earnings

Immunome (NASDAQ:IMNM) reported its Q2 earnings results on Friday, August 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Immunome beat estimated earnings by 1.33%, reporting an EPS of $-0.74 versus an estimate of $-0.75.

IMNM